Cell numbers are regulated by a balance among proliferation, growth arrest, and programmed cell death (apoptosis) (15, 42, 64) . Until recently, studies of oncogenesis have focused on regulation of cell proliferation (61) . The recognition that negative growth control, including growth arrest and programmed cell death, must be understood to comprehend how appropriate cell numbers are maintained and how alterations in any part of the equation can contribute to malignancy has led to a burst of work in this field (42, 57, 61, 62, 64) . Among the genes induced by various growth arrest and apoptotic stimuli are the tumor suppressor gene p53 (8, 32, 41) , myeloid differentiation primary response (MyD) genes (1, 2, (38) (39) (40) , growth arrest and DNA damage (GADD) genes (17) (18) (19) , growth arrest-specific (gas) genes (56) , and small proline-rich (spr) genes (31) . It is known that apoptosis is an active process requiring protein synthesis and specific endonucleolytic digestion of cellular DNA in many cases (65) ; however, little is understood about the intracellular mechanisms that lead to growth arrest and programmed cell death.
A profound example of cell homeostasis which is regulated throughout life is the complex process of blood cell formation, whereby a hierarchy of hematopoietic progenitor cells in the bone marrow proliferate and terminally differentiate along multiple, distinct cell lineages. This includes the proliferation and differentiation of myeloid precursor cells into mature granulocytes and macrophages (44, 51, 55) . As a first step towards dissection of the regulation of terminal differentiation, we have isolated MyD genes, induced in the absence of de novo protein synthesis following induction of differentiation of autonomously proliferating Ml myeloid leukemia cells, by using mouse lung conditioned medium (LCM), which contains interleukin-6 and leukemia-inhibitory factor (1, 2, 27, (38) (39) (40) .
Since growth arrest and apoptosis are part of the myeloid developmental program (58) , it was expected that some of the MyD genes would play a role in these processes. Consistent with this expectation, it has been shown that MyD32, which encodes interferon regulatory factor 1, participates in the suppression of growth during the myeloid differentiation program (2) . The novel genes MyD116 and MyD118 code for proteins that are strikingly similar to proteins encoded by two novel genes, gadd34 and gadd45, coordinately activated in hamster cells by GADD stimuli, including alkylating agents and irradiation (1, 17, 19, 40) . The observed homologies led to the conclusion that MyD116 and gadd34 are murine-hamster homologs of the same gene, whereas MyD118 and gadd45 represent two separate but closely related genes, defining a new family of growth arrest and DNA damage-inducing genes (17, 19, 33) . These homologies led us to surmise that MyD116 and MyD118 are involved in the growth arrest and apoptosis associated with the myeloid developmental program.
To molecularly dissect growth arrest and apoptosis, the myeloid leukemia Ml cell line was analyzed following treatment with transforming growth factor ,13 (TGFP1), which induces rapid growth arrest and apoptosis in Ml cells. TGF,3, a family of closely related peptides important in growth control, development, and differentiation, is a group of strong inhibitors of proliferation of most epithelial, endothelial, and hematopoietic cells (43, 48) , and in some cell types growth arrest is reversible (9, 35) but in others it is accompanied by programmed cell death (49, 53) . TGF,B1 has been implicated in the regulation of hematopoietic cell development (29, 54) . Although little is known about the mechanism of growth arrest by TGF,B1, a role for c-myc suppression has been suggested (48, 50) .
The putative players we chose to investigate for roles in growth arrest and apoptosis induced by TGF,1 were (i) the proto-oncogene c-myc, which has been implicated in the control of cell proliferation and differentiation (3, 11, 14, 24, 27, 36) , in which its suppression was suggested to play a pivotal role in TGFP1-induced growth inhibition of various cell types (48, 50) and its deregulated expression in cells deprived of growth factors (5, 15) or exposed to reversible growth-blocking conditions (6, 15) has been shown to stimulate apoptosis; (ii) the proto-oncogene c-myb, which, like c-myc, plays a role in the regulation of proliferation and differentiation (4, 20, 57) , but for which a role in apoptosis has not been reported; (iii) bcl-2, which has been shown to promote cell survival and inhibit apoptosis induced by many types of stimuli in certain cells (46, 47, 62, 66) ; and (iv) the novel MyD genes MyD116 and MyD118, which are described above.
By employing Ml cells and genetically engineered Ml cell variants to dissect the growth arrest and apoptosis induced by TGF,31, we demonstrated for the first time that (i) MyD118 is a primary response gene induced by TGFI1 which plays a positive role in the modulation of apoptosis; (ii) bcl-2 expression is down-regulated by TGF,B1, in which elevated expression of bcl-2 suppresses the TGF,B1-induced apoptotic pathway; (iii) proto-oncogenes c-myc and c-myb stimulate TGF,B1-mediated apoptosis, implicating c-myb for the first time in the regulation of apoptosis; and (iv) in all cases, the TGFP1-induced apoptotic response is correlated with the level of MyD1J8 expression. Taken together, these findings delineate a molecular-cellular network of interactions in which the differentiation-TGF,1 primary response gene MyD118 and protooncogenes participate to control growth arrest and apoptosis of hematopoietic cells.
MATERIALS AND METHODS
Cells and cell culture. The differentiation-competent murine Ml myeloid leukemic cell line and the Ml variant Mlmyc and Mlmyb cell lines have been described previously (27, 57, 58) . The data presented were obtained by using the Mlmyc2 and Mlmybll cell lines; however, for each cell variant, three independent cell lines were examined (Mlmyc2, MlmycS, and Mlmycl2 and Mlmyb3, Mlmyb7, and Mlmybll), and the results were similar to the data presented. Cells were cultured in Dulbecco's modified Eagle's medium (GIBCO) and 10% horse serum at 37°C in a humidified atmosphere with 10% CO2. Cells were seeded at 0.15 x 106/ml with or without appropriate treatments. For RNA extractions at early times following various treatments, cell concentrations were adjusted to give a final density of >0.25 x 106/ml at the time of extraction. Viable cell numbers were determined by trypan blue dye exclusion and counting in a hemocytometer. and MvlLu were obtained from the American Type Culture Collection.
,-Estradiol was obtained from Sigma and used at 2 ,uM. Porcine TGF,1 (R & D Systems) was used at a concentration of 10 ng/ml. Cycloheximide (Sigma) was used at 10 ,ug/ml. DNA transfections. Ml cells were transfected via electroporation (Bio-Rad Gene Pulser) with pMLV or pMLVASMyD 118 linearized by digestion with EcoRI, and transfectants were selected for resistance to Geneticin (G418 sulfate; 400 ,ug/ml; GIBCO) as previously described (27, 57) .
Retroviral infections. Recombinant plasmid pZip-bcl-2 and parental plasmid pZip-neo were constructed and packaged as infectious amphotropic retroviruses as described previously (46, 47) . Supernatants of clones of PA317 exhibiting the highest-titer virus production were used to infect Ml cells as previously described (45) . Selection for infected cells by resistance to G418 was the same as for transfectants. Assays for growth arrest and apoptosis. Viable cell numbers were determined by trypan blue dye exclusion and counting in a hemocytometer. DNA synthesis was measured by incorporation of [3H]thymidine into trichloroacetic acid-precipitable material, as previously described (28) , when cells were pulselabeled for 2 h. DNA fragmentation, indicative of apoptosis, was determined by a modification of a procedure previously described (59) , in which, after lysis of cells and treatment with proteinase K, samples were treated with RNase A and 5 ,ug of the purified sample was fractionated on a 2% agarose gel. Cytofluorometric analysis was performed as previously described (27) . Viable cells were stained with propidium iodide for analysis. DNA fragmentation and cytofluorometric analysis were done at least two, and sometimes three, times.
General recombinant DNA techniques, expression vectors, and DNA probes. Plasmid preparations, restriction enzyme digestions, DNA fragment preparations, and agarose gel electrophoresis were done as described before (27, 38) . Probes for murine c-myc, c-myb (murine), c-myb (human), MyD116, and MyD118 were the same as those used previously (1, 27, 40, 57); gadd45 was obtained from A. Fornace (17) . DNA for probes was labeled by random priming to a specific activity equal to or greater than 109 cpm/4Lg (16) . The pMLV expression vector was constructed by digesting pHb-APr-1-neo (23) with EcoRI and Sall to excise the ,-actin promoter and substituting the murine leukemia virus promoter (1.1-kb Spe fragment from pBC14) (63) by blunt-end ligation. To obtain pMLVASMyD 118, MyD118 cDNA containing the complete coding sequence (1) was blunt end ligated into the HindIII site of pMLV, and the antisense orientation was ascertained by appropriate restriction enzyme digestions.
RNA extraction, Northern (RNA) blotting, and hybridization. RNA was extracted by the method of Chomczynski and Sacchi (7), with guanidinium thiocyanate. Total RNA (5 ,ug per lane; the presence of equal amounts of RNA in all lanes was confirmed by the equal intensities of ethidium bromide staining of rRNA bands) was electrophoresed on 1% agaroseformaldehyde gels. Northern blots were prepared by using Duralon-UV membranes (Stratagene), and UV cross-linked (Stratalinker; Stratagene) prior to baking. The hybridization and washing conditions used and the method used to strip blots of the probe for rehybridization were described previously (38, 57) .
Reverse transcription (RT)-PCR. To assay for the presence of sense transcripts in MlAS118 cell lines, RT of total RNA with MyD118-specific 3' primers was carried out and followed by amplification as described by Kawasaki et al. (34) . Total Aliquots (10 Rl) were electrophoresed, blotted, and hybridized with a MyD118 probe. Control samples not reverse transcribed were used to monitor for possible contamination with genomic DNA. DNase treatment of RNA and RNase treatment following RT had no effect on the outcome.
Immunoblotting. To detect the c-Myc and c-Myb proteins, cell extracts were prepared, cell lysates were normalized for protein content, and 100 p.g of protein per lane was fractionated on sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis gels, blotted, probed, and washed as described by Selvakumaran et al. (57, 58) . The probes used were murine anti-c-Myc antibodies (OM-11-904; Cambridge Research Biochemicals) and sheep anti-c-Myb antibodies (OA-11-843; Cambridge Research Biochemicals). Bcl-2 protein was detected by using rabbit antiserum specific for the human Bcl-2 protein as described by Reed et al. (52) . Rabbit antiserum specific for the murine Bcl-2 protein was raised against a synthetic peptide corresponding to amino acids 68 to 86 of the murine Bcl-2 protein essentially by using methods described previously (52) .
RESULTS
Induction of growth arrest and apoptosis in Ml cells by TGFI1. Ml cells treated with TGF31 underwent growth arrest and apoptosis ( Fig. 1 and Table 1 ). Between 1 and 2 days following TGFp1 treatment, the cells ceased to proliferate (Fig. 1A) ; this was accompanied by inhibition of DNA synthesis and a block in cell cycle progression at GO-G1 (Table 1 ). In addition to growth arrest, TGFr1-treated Ml cells lost viability, as determined by failure to exclude trypan blue (Fig. 1B) , and underwent programmed cell death, as seen by distinct cell morphology, including chromatin condensation and cytoplasmic blebbing (Fig. 1C) , and DNA fragmentation (Fig. 2 ) resulting from cleavage of nuclear DNA in internucleosomal regions, a characteristic of apoptotic cells (65 MyDJ18 was rapidly induced and steady-state transcript levels peaked by 1 h (Fig. 3) . MyD118 also was expressed when Ml cells were concomitantly treated with TGF,B1 and cycloheximide, indicating that MyD118 is a primary response gene induced by TGF1l (Fig. 3) . As can be seen in Fig. 3 , MyD118 also is a primary response gene induced following TGFP1-mediated growth suppression of lymphoid cell line EL-4 and mink lung epithelial cell line MvlLu. Thus, it can be concluded that MyD118 is a primary response gene that is induced in the absence of de novo protein synthesis following induction of growth inhibition and apoptosis by TGF,B1 in Ml cells.
To determine whether a role in mediating the effects of TGF1l can be attributed to MyD118, Ml cell lines have been established which express antisense (AS) MyD118 transcripts at elevated levels, thereby blocking early expression of the MyD118 gene product (Fig. 4A and B) . The pMLV expression vector, containing the MyD118 cDNA cloned in the AS orientation, where it is under control of the murine leukemia virus promoter, was used; following transfection by electroporation, transfectants were selected by resistance to Geneticin (G418). Control Ml transfectants also were established by using the expression vector without the MyD cDNA. Three control cell lines analyzed behaved similarly to the parental Ml cell lines.
Of the many MlAS118 cell lines established, RNAs from three which expressed elevated levels of AS MyDJ18 transcripts are shown in Fig. 4A MyD118 in regulating programmed cell death and suggest that failure to express MyD118 at early times has no effect on growth arrest.
The elect of elevated expression of bcl-2 on TGFI1-mediated growth suppression and apoptosis of Ml cells. Elevated expression of the proto-oncogene bcl-2 has been shown to play a role in the promotion of cell survival by blocking programmed cell death induced by a wide variety of stimuli in certain types of cells (46, 47, 62, 66) . bcl-2 was expressed in Ml cells and downregulated following treatment with TGF,B1 ( express elevated levels of bcl-2 were established following retroviral infection of Ml with pZip-bcl-2 ( Fig. SB and C) . Bcl-2 protein from three of the many Mlbcl-2 cell lines established is shown in Fig. 5B . Southern blot analysis of each of these clones showed that each was an independent clone (data not shown). All of the experiments were carried out with these three Mlbcl-2 cell lines, and similar data were obtained. programmed cell death, as determined by exclusion of trypan blue, cell morphology, and DNA fragmentation ( Fig. 2 and  5F ). Even as late as 6 days, Mlbcl-2 cells appeared to be viable. Thus, overexpression of bcl-2 protected Ml cells from TGFI1-induced apoptosis. These results also demonstrated that TGF31 induces growth arrest independently of apoptosis in Ml cells.
Since MyD118 has been shown to be a positive modulator of TGFP1-induced apoptosis and overexpression of bcl-2 blocks apoptosis, it was of interest to ascertain whether expression of MyD118 is affected by elevated expression of bcl-2. As can be seen in Fig. SD , no or extremely reduced levels of MyD118 transcripts were apparent in Mlbcl-2 cells following treatment with TGFP1. These data suggest some interaction between bcl-2 and regulation of expression of MyDJ18, as well as the possibility that the effects of overexpression of bcl-2 are mediated, at least partially, through MyD118. In addition, our previous suggestion that MyD118 is not necessary for TGFI1-induced growth arrest is confirmed, and the notion of a positive role for MyD118 in TGFI31-induced apoptosis is reinforced.
Also, it can be asked whether the increased survival of TGF,B1-treated M1AS118 cells is mediated via increased levels of bcl-2. bcl-2 expression was suppressed in MlAS118 cells to the same degree as in Ml cells following treatment with TGF31 (Fig. 5A) , indicating that bcl-2 plays no role in the enhanced survival of MlAS118 cells.
Effect of deregulated expression of proto-oncogenes c-myc and c-myb on TGFRI-mediated growth arrest and apoptosis of Ml cells. It has been strongly suggested that suppression of the proto-oncogene c-myc plays a pivotal role in TGFI1-induced growth inhibition of various cell types (48, 50) . As shown in Fig. 6 and cells, all of which became growth arrested. For all of these cell lines, in addition to loss of proliferative capability, there was a drop in the rate of DNA synthesis and withdrawal from the cell cycle (Table 1) . Expression of the proto-oncogene c-myb was also rapidly suppressed by treatment of Ml with TGFI1 (Fig.  6 ). The availability of the Mlmyc and Mlmyb cell lines, in which c-myc or c-myb expression is deregulated (27, 57) , provided us with the opportunity to look at the antiproliferative and apoptotic effects of TGFpi1 in the setting of enforced production of c-myc or c-myb. Several independent lines of Mlmyc and Mlmyb were compared with parental Ml cells.
To ensure that the c-myc and c-myb transgenes were expressed in the TGF,B1-treated Mlmyc and Mlmyb cell lines, respectively, Northern blot and Western blot (immunoblot) analyses were performed. These analyses confirmed that exogenous c-myc mRNA and c-Myc protein continued to be present in Mlmyc cell and exogenous c-myb mRNA and c-Myb protein were present in Mlmyb cells following treatment with TGFpi1 (Fig. 6) .
In contrast to Ml cells, in TGF,B1-treated Mlmyc and Mlmyb cell lines, the rate of DNA synthesis fell only minimally and the cells continued to traverse the cell cycle (Table 1) . However, growth curves appeared very similar for the Ml, Mlmyc, and Mlmyb lines, whose cells proliferated for up to 24 h (data not shown) and then underwent loss of viability (Fig.  7A) . Interestingly, the Mlmyc and Mlmyb cell lines lost viability more rapidly than Ml cells, with Mlmyb cells responding even more rapidly than Mlmyc (Fig. 7A and B) . The appearance of fragmented DNA in the different cell lines was consistent with accelerated apoptosis (Fig. 7B) (Fig. 4, 5, and 7C ).
DISCUSSION
Using TGFf1-treated Ml myeloid leukemia cells and genetically engineered Ml variants to dissect the regulation of growth arrest and apoptosis, in this study we showed for the first time that (i) MyD118, a differentiation primary response gene which has been shown also to be a primary response gene induced by TGF,1, plays a positive role in the modulation of apoptosis; (ii) elevated expression of bcl-2 blocks the apoptosis but not the growth arrest induced by TGF,B1; (iii) continuous expression of either c-myc or c-myb inhibits growth arrest and accelerates apoptosis, and this is the first demonstration that c-myb plays a role in regulating apoptosis; and (iv) in all of these cases, the level of MyD1J8 expression correlated with the rapidity of the apoptotic response.
MyD118 is a positive regulator and bcl-2 is a negative regulator of apoptosis induced by TGFIB1. Since terminal myeloid differentiation encompasses growth arrest and apoptosis (58) , an overlap between the genetic responses to differentiation signals and TGF,1 is expected. MyD118, a MyD gene, also is a member of a family of genes which includes gadd45, which was recently shown to be a downstream effector of p53 required for cell cycle arrest following DNA damage (33) bcl-2 can promote cell survival by blocking apoptosis induced by a wide variety of circumstances ranging from growth factor deprivation to treatment with gamma radiation and chemotherapeutic drugs (12, 25, 46, 47, 66) . However, overexpression of bcl-2 does not prevent apoptotic cell death in all circumstances (13) , implying either that bcl-2 alone can be insufficient or that bcl-2-independent pathways for programmed cell death exist. We found that TGFI1-induced apoptosis was blocked by elevated bcl-2 expression and MyD118 was not induced, consistent with a positive role for MyD118 in the apoptotic response. These observations suggest some interaction between bcl-2 and regulation of MyD118 induction, as well as the possibility that the effect of bcl-2 is mediated via blocking of MyD118 expression. Studies on the interaction between bcl-2 and MyD118 and the apoptotic response are under way.
Deregulated c-myc and c-myb accelerate apoptosis. Deregulated expression of either c-myc or c-myb, which is rapidly downregulated in Ml cells following treatment with TGFI1, blocks TGFr1-induced arrest of DNA synthesis and withdrawal from the cell cycle but accelerates TGFP1-induced apoptosis. These findings are consistent with previous studies, in which a role for c-myc in the regulation of apoptosis was found in growth-arrested fibroblasts (15) , factor-deprived interleukin-3-dependent 32D myeloid cells (5) , and anti-T-cellreceptor antibody-stimulated T-cell hybridomas (60). Our findings obtained with TGFfi1 thus provide another indicator that continued expression of c-myc in the presence of growth arrest signals leads to apoptosis.
This work is the first reported demonstration that the proto-oncogene c-myb can regulate the apoptotic response. The accelerated apoptosis of TGF,1-treated Mlmyb cells is not mediated via continued expression of c-myc, since c-myc is suppressed with the same kinetics in both TGFr1-treated Ml and Mlmyb cells. It is intriguing that deregulated expression of c-myb in the myeloid Mlmyb cell line does not block TGFP1-induced suppression of c-myc, given the findings that c-myb transactivates the c-myc promoter in various lymphoid and myeloid cell lines (10) and interleukin-6-treated Mlmyb cells continue to express c-myc (57) . Unlike c-myc, which is expressed in almost all proliferating cell types (11) , c-myb is expressed predominantly in hematopoietic cells (22) . Thus, it will be interesting to ascertain whether c-myb can mediate apoptosis in other cell types, including those which do not normally express c-myb. During differentiation of primary cultures of myeloid precursor-enriched bone marrow cells, the patterns of expression of MyD118, c-myc, and c-myb closely resemble the situation in Ml cells (1, 37) . In addition, high levels of bcl-2 were observed in normal myeloid precursor cells and little or no expression was observed in terminally differentiated cells (26) . TGFI1, expressed in bone marrow, can modulate and regulate bone marrow-derived cells throughout their functional life span, and its pleiotropic effects depend on cell lineage, specific cellular phenotype, stage of differentiation, immediate microenvironment, other cytokines, and cellular function (29, 54) . Taken together, the network of interactions elucidated in this work should help to provide insights into the complex controls that regulate myeloid cell homeostasis in vivo and the alterations in gene expression that play a role in the development of preleukemic myeloproliferative syndromes and the progression to leukemias.
MyDI18, myb, myc, AND bcl-2 IN TGFP1-INDUCED APOPTOSIS
